SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending due to market volatility sparked by uncertainty surrounding the ongoing military conflict with Iran, with participants actively debating the company's fundamentals against the backdrop of broader geopolitical instability. The discussion on social platforms is highly polarized, focusing on skepticism regarding official administration announcements, concerns over economic repercussions, and intense commentary on leadership credibility.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is facing a significant sell-off as investors react to two consecutive legal losses in California regarding addictive design, with community members fiercely debating whether to blame the platform's algorithms or personal responsibility. While some traders are expressing extreme bearish sentiment and fear that these rulings create a precedent for thousands of future lawsuits, others view the sharp pullback as a buying opportunity, emphasizing that the company's underlying fundamentals and revenue generation remain intact.

Unity Software, Inc. engages in the developing video gaming software. It also provides software solutions to create, run and monetize interactive, real-time two-dimensional and three-dimensional content for mobile phones, tablets, consoles, and augmented and virtual reality devices. Its platform is used by developers, artists, and designers to build content for gaming, film, retail, automotive, architecture, engineering, and construction industries. The company was founded by Joachim Ante and David Helgason in 2004 and is headquartered in San Francisco, CA.

Unity Software Inc

Unity Software is seeing heightened volatility and investor scrutiny as the stock faces continued selling pressure, with community sentiment split between those viewing the current valuation as a deep-value buying opportunity and others concerned by broader sector headwinds. Investors are actively debating the company's long-term pivot toward its 'Grow' and advertising segments while keeping a close watch on potential catalysts like upcoming product demos and rumors surrounding the sale of the Unity China division.

Madrigal Pharmaceuticals, Inc. engages in the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product, MGL-3196, is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. The company was founded by Rebecca A. Taub, Frederick Bernard Craves, and Edward Chiang on March 10, 2000 and is headquartered in West Conshohocken, PA.

Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals is trending as investors digest a wave of positive analyst upgrades and persistent M&A speculation, with the community actively debating whether the stock's long-term potential as the first-to-market MASH treatment justifies current valuations. While sentiment remains divided between those expecting a near-term buyout and those favoring a long-term hold, discussions are heavily focused on the company's ability to maintain its market lead amidst expanding competition.

Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.

Kodiak Sciences Inc

Kodiak Sciences is seeing significant investor attention and upward momentum following positive topline results from the Phase 3 GLOW2 study of Zenkuda for diabetic retinopathy, which demonstrated clear superiority over sham treatment. The community is actively debating the stock's potential for a short squeeze given its high short interest and the strategic implications of the trial's success, while some traders closely monitor the company's cash position and potential for future capital raises.

Procter & Gamble Co. engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances. The Health Care segment includes oral care products like toothbrushes, toothpaste, and personal health care such as gastrointestinal, rapid diagnostics, respiratory, and vitamins, minerals, and supplements. The Fabric and Home care segment consists of fabric enhancers, laundry additives and detergents, and air, dish, and surface care. The Baby, Feminine and Family Care segment sells baby wipes, diapers, and pants, adult incontinence, feminine care, paper towels, tissues, and toilet paper. The company was founded by William Procter and James Gamble in 1837 and is headquartered in Cincinnati, OH.

Procter & Gamble Co.

Procter & Gamble is seeing active community discussion around its structural support levels near $150, with investors debating whether the stock represents a defensive value opportunity or a potential falling knife. Traders are closely monitoring the company's dividend reliability and operational efficiency plans while analyzing institutional sentiment ahead of upcoming earnings.

Carnival Corp. engages in the operation of cruise ships. It operates through the following business segments: North America Cruise Operations, Europe Cruise Operations, Cruise Support, and Tour and Others. The North America Cruise Operations segment includes the Carnival Cruise Line, Holland America Line, Princess Cruises, and Seabourn. Europe Cruise Operations segment consists of AIDA, Costa, Cunard, and P&O Cruises (UK). The Cruise Support segment represents port destinations and private islands for the benefit of its cruise brands. The Tour and Other segment operates hotel and transportation operations of Holland America Princess Alaska Tours. The company was founded in 1972 and is headquartered in Miami, FL.

Carnival Corp. - Ordinary Shares (Paired Stock)

Carnival Corp

Carnival Corp (CCL) is experiencing significant downward pressure as investors rotate out of travel stocks amid escalating geopolitical tensions in the Middle East and a sharp spike in crude oil prices. While the community remains deeply divided between those citing oversold valuations and record cruise demand versus those fearing a prolonged sector downturn, the stock is seeing heightened volatility as traders weigh the potential for a recovery against the threat of sustained high fuel costs.

GraniteShares ETF Trust - GraniteShares 2x Long MU Daily ETF

GraniteShares 2x Long MU Daily ETF

MULL is seeing heavy trading activity as investors leverage it as a high-volatility vehicle to play the price action of Micron, with many users actively scalping the swings or accumulating shares on dips. The community is fiercely debating the stock's future potential, with bulls citing technical strength and upward momentum while others warn about the risks of volatility decay inherent in leveraged ETFs.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

The SPY is trending as traders grapple with extreme volatility and geopolitical uncertainty, with the community actively debating whether recent "taco" announcementspresidential tweets delaying strikes on Iranian energy sitesare genuine catalysts for a recovery or merely temporary market manipulation. Investors are increasingly skeptical of these repeated deadline extensions, leading to a focus on institutional accumulation patterns versus potential technical breakdowns as the market navigates significant risk-off sentiment.

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand is seeing increased community debate as investors react to the appointment of a new Board Chair, Bill Barhydt, alongside a significant workforce reduction and a strategic pivot toward real-world asset tokenization. While some traders express frustration over long-term price performance and recent lows, others remain focused on the network's high transaction throughput and potential institutional adoption as a foundation for future utility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>Nebius stated that it intends to use the proceeds from the issue of these convertible notes to finance the expenditures related to the construction and build-out of its data centers.</li><li>The company also added that it will use these funds to make investments in developing its full-stack AI cloud as well as expand its data center footprint.</li><li>Nebius also plans to use the funds to procure key components such as graphics processing units, which are essential for its data center ambitions.</li></ul>Nebius Group NV (NBIS) shares declined more than 11% in Tuesday’s opening trade after the company announced a proposed private offering of $3.75 billion of convertible senior notes.The company said it will offer the convertible notes in two series totaling $3.75 billion, with $2 billion in the first and $1.75 billion in the second.Retail sentiment on Stocktwits around&nbsp;<a href="https://stocktwits.com/symbol/NBIS">Nebius</a> trended in the ‘bullish’ territory with message volumes at ‘extremely high’ levels.This follows a 15% surge on Monday after Nebius struck a&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-is-nbis-stock-soaring-today/cZ32HbcRIfW">$27 billion deal</a> with Meta Platforms Inc. (META) in a long-term agreement for AI infrastructure buildout.<h2 class="st-heading-2">What Does Nebius Intend To Use These Funds For?</h2>Nebius stated that it intends to use the proceeds from the issue of these convertible notes to finance the continuing growth of its business, including expenditures related to the construction and build-out of its data centers.The company added that it will use these funds to make investments in developing its full-stack AI cloud as well as expand its data center footprint. Nebius also plans to use the funds to procure key components such as graphics processing units (GPU), which are essential for its data center ambitions.<h2 class="st-heading-2">Nebius’ Multi-Billion Dollar Deals</h2>On Monday, Nebius struck a long-term deal with Meta to provide the latter with dedicated capacity across locations. The company also stated that Meta has committed to purchase additional available compute capacity across certain upcoming Nebius clusters up to a total of $15 billion during this period.Prior to this deal, Meta and Nebius struck a $3 billion agreement in November 2025 for AI infrastructure. The Dutch company said the contract had to be limited to the capacity Nebius had available.Nebius also signed a $17.4 billion agreement with Microsoft Corp. (MSFT) in September 2025 to deliver AI infrastructure.<a href="https://stocktwits.com/symbol/NBIS">NBIS stock</a> is up 40% year-to-date and 314% over the past 12 months. The iShares Core MSCI EAFE ETF (IEFA) is up 18% over the past 12 months, while the iShares MSCI EAFE ETF (EFA) is up 17%.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/iran-supreme-leader-khamenei-rejects-ceasefire-with-us-crude-oil-prices-rise/cZ3Ec2ARIQM">Iran's New Supreme Leader Reportedly Rejects Proposal For Ceasefire With US – Crude Oil Prices Rise Amid Growing Tensions</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Nebius Group logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

What Is Pulling NBIS Stock Down Today?

The company said it will offer the convertible notes in two series totaling $3.75 billion, with $2 billion in the first and $1.75 billion in the second.

Equity

<ul class="summary-bullets"><li>Nebius stated that Meta has committed to purchase additional available compute capacity across some of its upcoming clusters, totaling to $15 billion.</li><li>The company added that while it intends to sell additional cloud compute capacity of its upcoming clusters to third-party customers, Meta will take up the remaining capacity.</li><li>Nebius stated that the delivery of this AI infrastructure capacity using Nvidia’s Vera Rubin platform will begin in early 2027.</li></ul>Nebius Group NV (NBIS) shares soared more than 15% in Monday’s pre-market trade after the company announced a new long-term AI infrastructure agreement with Meta Platforms Inc. (META).Under the five-year agreement, Nebius stated that it will provide $12 billion in dedicated capacity to Meta across its locations. The company said that this will be one of the first large-scale deployments of Nvidia Corp.’s (NVDA) new Vera Rubin platform.The company also stated that Meta has committed to purchase additional available compute capacity across certain upcoming Nebius clusters up to a total of $15 billion during this period.Retail sentiment on Stocktwits around&nbsp;<a href="https://stocktwits.com/symbol/NBIS">Nebius</a> trended in the ‘bullish’ territory with message volumes at ‘high’ levels. NBIS was the top trending ticker on Stocktwits at the time of writing.<h2 class="st-heading-2">Delivery To Begin Early 2027</h2>Nebius stated that the delivery of this AI infrastructure capacity using Nvidia’s Vera Rubin platform will begin in early 2027.The company added that while it intends to sell additional cloud compute capacity of its upcoming clusters to third-party customers, Meta will take up the remaining capacity.Nebius added that its 2026 fiscal guidance remains unchanged. During its fourth-quarter (Q4) earnings call, the company guided 2026 revenue to be in the $3 billion to $4 billion range, while the Wall Street consensus estimate is at $3.33 billion, according to Fiscal.ai data.“We are pleased to expand our significant partnership with Meta as part of securing more large, long-term capacity contracts to accelerate the build-out and growth of our core AI cloud business,” said Nebius founder and CEO, Arkady Volozh.<h2 class="st-heading-2">Meta’s Ongoing Partnership With Nebius</h2>Meta’s new $27 billion deal with Nebius builds on an ongoing partnership between the two companies. Meta and Nebius struck a $3 billion deal in November 2025 for AI infrastructure. The Dutch company said that this contract had to be restricted to the capacity that Nebius had available.Prior to the Meta deal, Nebius signed a $17.4 billion agreement with Microsoft Corp. (MSFT) in September 2025 to deliver AI infrastructure.<a href="https://stocktwits.com/symbol/NBIS">NBIS stock</a> is up 35% year-to-date, while&nbsp;<a href="https://stocktwits.com/symbol/NBIS">META stock</a> is down 7%. The iShares Core MSCI EAFE ETF (IEFA) is up 18% over the past 12 months, while the iShares MSCI EAFE ETF (EFA) is up 17%.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/elon-musk-macrohard-digital-optimus-working-on-tesla-cars-ai4-hardware/cZduO5mRI9M">Elon Musk Says 'Digital Optimus' Works On All Tesla Cars Equipped With AI4 Hardware</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Why Is NBIS Stock Soaring Pre-Market Today?

Nebius stated that the five-year agreement will include one of the first large-scale deployments of Nvidia’s new Vera Rubin platform.

Zacks Investment Ideas feature highlights EFA and SPY

EFA and SPY have been highlighted in this Investment Ideas article.


US and International Equities: A Narrowing Gap?

After more than a decade of underperformance, international equities posted a considerably better year than US equities in 2025. Is this a structural, or cyclical shift?

<ul class="summary-bullets"><li>Despite the mixed Q4 performance, Sea CEO Forrest Li stated that 2025 was a great year for the company and that all its businesses scaled well, exceeding Sea’s growth expectations.</li><li>The company Shopee served around 400 million active buyers, Monee gained over 20 million unique first-time borrowers, and Garena connected on average with more than 100 million players daily throughout 2025.</li><li>Shopee’s gross merchandise value stood at $36.7 billion, growing 28.6% YoY, while core marketplace revenue surged by over 50% to $3.6 billion.</li></ul>Sea (SE) American Depository Receipts tumbled nearly 25% in Tuesday’s opening trade after the company reported mixed fourth-quarter (Q4) results, and the intensifying war in the Middle East pushed the broader markets down.The Singapore-based tech conglomerate reported earnings per share (EPS) of $0.63 on revenue of $6.85 billion, while Wall Street analysts expected an EPS of $0.81 on revenue of $6.43 billion, according to Fiscal.ai data.Sea is the holding company for the popular online games developer Garena, the digital payments and financial services provider Monee, and the e-commerce platform Shopee.<h2 class="st-heading-2">All Businesses Scaled Well, Says CEO</h2>Despite the mixed Q4 performance, Sea CEO Forrest Li stated that 2025 was a great year for the company and that all its businesses scaled well, exceeding Sea’s growth expectations.“In 2025, Shopee served around 400 million active buyers and 20 million sellers. Monee gained over 20 million unique first-time borrowers. And Garena connected on average with more than 100 million players daily throughout the year,” Li said.Sea stated in its announcement that Shopee registered a 30.5% year-on-year increase in Q4 gross orders. Gross merchandise value (GMV) stood at $36.7 billion, growing 28.6% YoY, while core marketplace revenue surged by over 50% to $3.6 billion.Sea’s financial services firm Monee registered an 80.4% YoY increase in its consumer as well as small and medium enterprises (SME) loans, which stood at $9.2 billion as of Dec. 31, 2025.Garena, Sea’s online games firm, registered a 23.8% YoY increase in bookings to $672.4 million in Q4, while quarterly active users edged up by 2.5% YoY to 633.3 million. Average bookings per user rose to $1.08, up from $0.88 in the same quarter a year ago.The company also provided an update on its $1 billion share repurchase program, stating that it had bought back shares worth $14.5 million in Q4.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment on Stocktwits around&nbsp;<a href="https://stocktwits.com/symbol/SE">Sea</a> trended in the ‘extremely bullish’ territory, with message volumes at ‘extremely high’ levels.One user flagged potential margin compression at Shopee, noting that the company still needs to demonstrate whether its long-term target of 2% to 3% GMV margins is achievable.<stembedurl>https://stocktwits.com/StockPlaza/message/646417862</stembedurl><a href="https://stocktwits.com/symbol/SE">SE ADR</a> is down 39% year-to-date and 38% over the past 12 months.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/trump-warns-iran-too-late-for-talks/cZdehIWRIPe">Trump Warns It's 'Too Late' For Talks With Iran, Says Their Air Force, Navy, And Leadership Are Gone</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Sea Ltd. is a Singapore-based global consumer internet company operating platforms such as Shopee, Garena, and Moneee

SE Stock Is Tumbling Today — Mixed Q4 Results Offer Little Hope Amid Raging Middle East Conflict

Singapore-based tech conglomerate Sea reported earnings per share of $0.63 on revenue of $6.85 billion, while Wall Street analysts expected an EPS of $0.81 on revenue of $6.43 billion.

<ul class="summary-bullets"><li>Nebius and CoreWeave are both neocloud or artificial intelligence infrastructure providers with GPU-first data centers.&nbsp;</li><li>Retail touted the dip in NBIS stock as a ‘buying opportunity,’ while also calling the company’s shares superior to CoreWeave’s because of its lower leverage.</li><li>CoreWeave has long-term debt of $14.67 billion as of Dec. 31, 2025, while Nebius has long-term debt of $4.1 billion as of the same date.</li></ul>Shares of Amsterdam-based Nebius Group N.V. (NBIS) slumped more than 13% on Friday amid a decline in rival CoreWeave Inc.'s (CRWV) shares. &nbsp;CoreWeave on Thursday <a href="https://stocktwits.com/news-articles/markets/equity/crwv-stock-slumps-on-coreweave-capex-projections-for-2026/cZTcmZKRITh">announced</a> that its capital expenditure plans for 2026 would be more than double of 2025, sending its shares down in Friday’s trade.Nebius and CoreWeave are both neocloud or artificial intelligence infrastructure providers with GPU-first data centers. Both companies are backed by Nvidia Corp. (NVDA) and operate on its chips.<h2 class="st-heading-2">What Is Retail Saying?</h2>On Stocktwits, retail sentiment around NBIS shares was in the ‘bullish’ territory amid ‘normal’ message volumes at the time of writing. The stock was among the most-trending on the platform.One bullish user said that CoreWeave’s dip just gave the market an ‘incredible buying opportunity.’<stembedurl>https://stocktwits.com/dailyalpha_2228/message/646097684</stembedurl>&nbsp;Another bullish user said that compute would be the future of the market and called it a ‘gift dip’.<stembedurl>https://stocktwits.com/Source206/message/646123644</stembedurl>&nbsp;A third user called Nebius the ‘winner’ when compared to CoreWeave.<stembedurl>https://stocktwits.com/omz24/message/646121668</stembedurl>&nbsp;Another bullish user gave Nebius the thumbs up, while giving CoreWeave a thumbs down, citing capital structure differences.<stembedurl>https://stocktwits.com/santacruztodd/message/646047422</stembedurl>&nbsp;<h2 class="st-heading-2">Capital Expenditure</h2>For 2026, CoreWeave has forecasted capital expenditure of $30 billion to $35 billion in 2026, compared to $14.9 billion spent in 2025. The company also reported long-term debt of $14.67 billion as of Dec. 31, 2025, compared to $5.4 billion as of Dec. 31, 2024.<figure class="image"><img src="https://news.stocktwits-cdn.com/Core_Weave_Long_Term_Debt_jpg_36378b7d22.webp" alt="CoreWeave_Long-Term_Debt.jpg" width="1600" height="1134"><figcaption>CoreWeave Debt From Dec. 2023 to Dec. 2025 | Source: Fiscal.ai</figcaption></figure>&nbsp;In comparison, Nebius reported long-term debt of $4.1 billion as of Dec. 31, 2025, a notable increase from zero debt the previous year, as it catches up to growing competition in the AI cloud market. Yet, its debt is significantly lower than that of CoreWeave’s.<figure class="image"><img src="https://news.stocktwits-cdn.com/Nebius_Group_Long_Term_Debt_jpg_898dd44895.webp" alt="Nebius_Group_Long-Term_Debt.jpg" width="1600" height="1134"><figcaption>Nebius had near-zero debt in 2023 and 2024 | Source: Fiscal.ai</figcaption></figure>&nbsp;However, Arkady Volozh, founder and CEO of Nebius, said in a <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://assets.nebius.com/assets/e59fb92e-9027-473a-8cac-04f9d2e9ea9a/Shareholder%20Letter%20Q4%202025.pdf?cache-buster=2026-02-12T11:43:13.446Z">letter to shareholders</a> on Feb. 12 that the company would “maintain a disciplined approach to raising capital” even as it considers a range of financing options for 2026, including corporate debt and asset-backed financing.<a href="https://stocktwits.com/symbol/NBIS">Shares of NBIS</a> have risen more than 178% in the past year, while s<a href="https://stocktwits.com/symbol/CRWV">hares of CRWV</a> have gained more than 93% in the same period.For updates and corrections, email newsroom[at]stocktwits[dot]com.Also Read: <a href="https://stocktwits.com/news-articles/markets/equity/coreweave-ceo-justifies-capex-spend-amid-stock-price-plummet-touts-high-demand/cZTcYsFRIT8">CoreWeave CEO Justifies Capex Spend Amid Stock Price Plummet, Touts High Demand: ‘Our Backlog Is Enormous’</a>

In this photo illustration, the Nebius Group logo is seen displayed on a smartphone screen. 

NBIS Stock Tanks Amid CoreWeave Decline — What Does Retail Think? 

CoreWeave on Thursday announced that its capital expenditure plans for 2026 would be more than double of 2025, sending its shares down in Friday’s trade. 

NBIS Stock Tanks Amid CoreWeave Decline — What Does Retail Think?

May 29th Options Now Available For iShares Trust - iShares MSCI EAFE ETF (EFA)

Investors in iShares Trust - iShares MSCI EAFE ETF (Symbol: EFA) saw new options become available today, for the May 29th expiration. One of the key inputs that goes into the price an option buyer is...

<ul class="summary-bullets"><li>TEV-'749 is designed to help improve patient adherence. &nbsp;</li><li>The treatment utilizes a copolymer technology proprietary to Medincell to provide a controlled steady, sustained release of olanzapine.</li><li>Earlier this week, the United States Court of Appeals for the Federal Circuit issued a ruling backing Teva in a patent dispute involving Corcept Therapeutics’ Korlym tablets.</li></ul> U.S. affiliate of Teva Pharmaceutical Industries Ltd. (TEVA) said on Friday that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for olanzapine extended-release injectable suspension or TEV-'749 for the treatment of schizophrenia in adults.The application was based on data from a late-stage trial in which TEV-'749 administered as a once-monthly subcutaneous injection demonstrated an efficacy and safety profile consistent with currently available olanzapine formulations and showed no evidence for the need for post-injection monitoring.Shares of TEVA traded marginally lower at the time of writing.<h2 class="st-heading-2">Drug Details</h2>Currently, long-acting olanzapine formulations require administration in a certified healthcare facility and require a 3-hour post-injection monitoring period. TEV-'749 is designed to help improve patient adherence. &nbsp;“Treatment adherence remains a major challenge and unmet need for people living with schizophrenia…,” &nbsp; said Eric Hughes, Chief Medical Officer at Teva. The treatment utilizes a copolymer technology proprietary to Medincell to provide a controlled steady, sustained release of olanzapine.Schizophrenia is a chronic, progressive and severely debilitating mental disorder that affects how one thinks, feels and acts, and symptoms may include delusions, hallucinations, disorganized speech or behavior and impaired cognitive ability. As per the company, about 1% of the world’s population will develop schizophrenia in their lifetime.Teva is best known for its generics business. Earlier this week, the United States Court of Appeals for the Federal Circuit issued a <a href="https://stocktwits.com/news-articles/markets/equity/cort-stock-drops-after-appeals-court-sides-with-teva-in-korlym-patent-fight/cZRkeLuR4DQ">ruling backing</a> Teva in a patent dispute involving Corcept Therapeutics’ Korlym tablets.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around TEVA stayed within the ‘bearish’ territory while message volume stayed at ‘low’ levels.<a href="https://stocktwits.com/symbol/TEVA">TEVA stock</a> has more than doubled over the past 12 months.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/praxis-precision-shares-rally-on-price-target-hikes/cZRNLcYR4xs">Praxis Precision Shares Rally On Price Target Hikes: Analyst Sees Upside As High As 100% For Stock</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Teva Pharmaceutical Industries logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

Teva Pharmaceuticals Seeks FDA Greenlight For New Schizophrenia Treatment 

The application was based on data from a late-stage trial in which TEV-'749 administered as a once-monthly subcutaneous injection demonstrated an efficacy and safety profile consistent with currently available olanzapine formulations.

See Which Of The Latest 13F Filers Holds EFA

At Holdings Channel, we have reviewed the latest batch of the 28 most recent 13F filings for the 12/31/2025 reporting period, and noticed that iShares Trust - iShares MSCI EAFE ETF (Symbol: EFA) was...

Noteworthy ETF Inflows: EFA, SPOT, SE, TEVA

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares MSCI EAFE ETF (Symbol: EFA) where we have detected an...

iShares Trust - iShares MSCI EAFE ETF

Alphabet $GOOGL

Robinhood $HOOD

Rocket Lab $RKLB

Sandisk $SNDK

The ticker that owned the conversation. This award honors the stock that defined the market narrative through engagement, price action, and cultural presence on the boards.

EFA
iShares MSCI EAFE ETF

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest EFA News

EFAiShares MSCI EAFE ETF